Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents

Purpose

This research study collects health-related information and blood samples to better understand how body composition, lifestyle habits, and diet influence meta-inflammatory monocytes (MiMos) in adolescents. The hypothesis of this study is that adolescents at risk for metabolic disease have enhanced MiMo related activities leading to insulin resistance.

Conditions

  • Type 2 Diabetes
  • Insulin Resistance
  • Obesity
  • Metabolic Disease
  • PreDiabetes

Eligibility

Eligible Ages
Between 14 Years and 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Between 14 and 18 years of age - Tanner stage 4 or 5 (mature adult stage of puberty) - Normal weight (BMI ≥ 5th percentile & < 85th percentile), overweight (BMI > 86th percentile) & < 94th percentile), obese weight (BMI percentile ≥ 95th percentile), and/or pre-diabetes (HbA1c > 5.7%) - For Type 2 Diabetes cohort, diagnosis of Type 2 Diabetes

Exclusion Criteria

  • Currently pregnant - Use medications known to affect glucose metabolism (immunosuppressive medications, cancer medications, or high dose steroids), unless prescribed for Type 2 Diabetes management - Prior diagnosis of autoimmune disease, cancer, or a cognitive or perceptual disability that would inhibit following directions of study staff - Allergies or intolerance to milk, soy, or palm oil

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross-Sectional

Arm Groups

ArmDescriptionAssigned Intervention
Normal weight BMI ≥ 5th percentile & < 85th percentile
Obese weight BMI ≥ 95th percentile
PreDiabetes HbA1c > 5.7%
Type 2 Diabetes Diagnosed with Type 2 Diabetes
Overweight BMI > 86th percentile and <94th percentile

Recruiting Locations

University of Michigan
Ann Arbor, Michigan 48109

More Details

Status
Recruiting
Sponsor
University of Michigan

Study Contact

The Singer Lab Team
(734) 615-4938
MiMoStudy@med.umich.edu